P21

P21 (also known as P021) is a synthetic tetrapeptide derived from the biologically active region of human ciliary neurotrophic factor (CNTF). Featuring an adamantylated glycine modification for enhanced blood-brain barrier penetration and metabolic stability, P21 promotes neurogenesis, enhances synaptic plasticity, and has shown significant cognitive benefits in preclinical models of Alzheimer's disease, traumatic brain injury, and age-related cognitive decline.

• Memory Enhancement
• Learning Acceleration
• Neurogenesis Promotion

Rapid CNS delivery via olfactory and trigeminal nerve pathways, bypasses hepatic first-pass metabolism, potentially lower doses needed compared to subcutaneous, non-invasive administration. May provide more pronounced acute cognitive effects.

Intranasal administration exploits the direct anatomical connection between nasal mucosa and brain via olfactory and trigeminal nerve pathways. This provides rapid CNS delivery while minimizing systemic exposure. P21's lipophilic adamantane modification enhances mucosal absorption and subsequent brain penetration.

Peak plasma concentration: 15 min. Elimination half-life: 6 hrs. Largely cleared by: ~1.3 days.

Research protocols from published literature — not dosing recommendations.

• Adamax — Synergistic: Adamax incorporates adamantyl portion from P21, may complement cognitive benefits through different neuropeptide pathways
• Semax — Compatible: Both are neuropeptides with established nootropic effects. Different mechanisms (CNTF vs melanocortin) may provide complementary cognitive benefits
• Selank — Compatible: Complementary cognitive and anxiolytic effects through different receptor systems
• Dihexa — Use Caution: Both affect neuroplasticity strongly through different pathways (CNTF/BDNF vs HGF/c-Met) - avoid concurrent use without careful cycling
• BPC-157 — Compatible: Different mechanisms - P21 targets neurogenesis/cognition, BPC-157 focuses on tissue repair and gut-brain axis
• Cerebrolysin — Similar: P21 was developed as a defined alternative to Cerebrolysin. Both promote neurogenesis but P21 has defined structure and better BBB penetration
• NAD+ — Compatible: Complementary mechanisms - NAD+ supports cellular energy metabolism while P21 promotes neurogenesis and synaptic plasticity
• Epitalon — Compatible: Different mechanisms - Epitalon targets telomerase/pineal function while P21 focuses on neurogenesis and cognitive enhancement

Minutes-Hours: Potential acute cognitive enhancement. Week 1-2: Cumulative cognitive improvements. Week 2-4: Enhanced memory and focus. Week 4-6: Full neuroplasticity benefits. Note: P21 has highly cumulative effects - low, slow dosing is recommended.

Use sterile nasal spray equipment. Clear nasal passages before administration. May cause temporary nasal irritation. CRITICAL: No human clinical trials have been conducted. Start with lower doses to assess tolerance. Consult healthcare provider before use. All benefits are based on preclinical and anecdotal data.

Use sterile nasal spray equipment. Clear nasal passages before administration. May cause temporary nasal irritation. CRITICAL: No human clinical trials have been conducted. Start with lower doses to assess tolerance. Consult healthcare provider before use. All benefits are based on preclinical and anecdotal data.

P21 should be stored at Fridge 2-8°C, use within 14-21 days.